Siliq™ (brodalumab) – New drug approval
February 15, 2017 – The FDA announced the approval of Valeant’s Siliq (brodalumab), for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies.
Top